Schizophrenia research heads NIMH priorities.
D003131:Combined Modality Therapy; D003866:Depressive Disorder / Q000628:therapy; D006801:Humans; D007099:Imipramine / Q000627:therapeutic use; D009315:National Institute of Mental Health (U.S.); D012008:Recurrence; D012106:Research; D012559:Schizophrenia / Q000628:therapy*; D014481:United States
D007099:Imipramine